UNSPSC 41131704: Activated whole blood clotting time tests

In this classification an activated whole blood clotting time tests is a device, used to monitor heparin therapy for the treatment of venous thrombosis or pulmonary embolism by measuring the coagulation time of whole blood US FDA regulates Activated whole blood clotting time tests under 21 CFR 864.7140 and under FDA product code JBP.

UNSPSC 41131704 Activated whole blood clotting time tests is a Commodity-level code with minimal recent state and local procurement activity explicitly tied to its nominal scope. The recent opportunities tagged under this code do not reflect clotting-time laboratory testing; instead, they span offender drug screening, naloxone procurement, urinalysis for family treatment courts, psychiatric drug-level assays, forensic drug standards, employment physicals and drug testing, employment screening services, and breath alcohol testing devices. None of these represent activated clotting-time assays or the hematology testing that the code name suggests. The mismatch indicates that this code either receives limited current solicitation volume for its stated purpose or is being applied inconsistently by issuing bodies to broader substance-testing and clinical-evaluation categories that fall outside its narrow technical scope.

The recent opportunities do show activity across state agencies, counties, cities, and special-purpose entities — Collin County Community Supervision and Corrections Department (Texas), Seminole County (Florida), Benton County (Oregon), State of Oregon, Pinellas County (Florida), Collier County (Florida), Clay County (Florida), City Colleges of Chicago, and Nevada Department of Public Safety — but none explicitly procure activated clotting-time testing. Collin County issued RFP 2026-327 for offender specimen collection and drug testing with a July 23, 2026 response date and $600,000 estimated value; Clay County released IFB 2526054 for physicals and drug testing due February 26, 2026; and Benton County posted RFP SC0200300017156 for urinalysis testing due July 7, 2026. Given the absence of actual clotting-time test procurement in the recent record, this code does not present a clear market signal for business development purposes at this time.